Chi-yuan Hsu, MD, MSc
Learn more about subscription options.
Register Now for a free account.
Hsu C. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD. Ann Intern Med. 2010;153:JC5–3. doi: 10.7326/0003-4819-153-10-201011160-02003
Download citation file:
Published: Ann Intern Med. 2010;153(10):JC5-3.
Cardiology, Chronic Kidney Disease, Coronary Risk Factors, Hematology/Oncology, Hypertension.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only